出版：MarketsandMarkets（マーケッツアンドマーケッツ） 出版年月：2024年4月
Dental Bone Graft Substitutes Market – Global Forecast to 2029
歯科用骨移植片代替物市場 : タイプ (異種移植片、同種移植片、合成骨移植片、アロプラスト)、用途 (サイナスリフト、隆起隆起、ソケット温存)、製品 (BioOss、骨移植片、グラフトン)、エンドユーザー、地域別 – 2029年までの世界予測
Dental Bone Graft Substitutes Market by Type ( Xenograft, Allograft, Synthetic Bone Grafts, Alloplast), Application (sinus Lift, Ridge Augumentation, Socket Preservation), Product (BioOss, Osteograf, Grafton), End User, Region- Global Forecast to 2029
| ページ数 | 284 |
| 図表数 | 310 |
| 価格 | |
| シングルユーザライセンス | USD 4,950 |
| マルチユーザライセンス（5名） | USD 6,650 |
| コーポレートライセンス | USD 8,150 |
| エンタープライズサイトライセンス | USD 10,000 |
| 種別 | 英文調査報告書 |
Report Overview
The global dental bone graft substitute market is projected to reach USD 1.8 billion in 2029 from USD 1.3 billion in 2024, at a CAGR of 7.7% between 2024 and 2029.
世界の歯科用骨移植片代替物市場は、2024年から2029年までのCAGRが7.7%で、2024年の13億ドルから2029年には18億ドルに達すると予測されています。
The growing elderly population is more susceptible to tooth loss and jawbone deterioration, potentially requiring bone grafting procedures. Dental implants offer a natural-looking and functional tooth replacement option, driving the demand for bone grafts to support implant placement which further contributes to market growth. On the other hand, stringent regulatory compliance and complexities in supply chain management are expected to limit market growth to a certain extent.
“Based on the mechanism, the osteoconduction segment is expected to grow by the highest CAGR in the dental bone graft substitute market.”
Advancements in osteoconductive materials allow for the development of smaller and more manageable bone graft particles. This facilitates minimally invasive surgical techniques for bone grafting procedures, leading to faster patient recovery also osteoconductive materials provide a scaffold or framework for bone cells to grow on and migrate into. This stimulates the body’s natural bone healing process, promoting the formation of new bone tissue which is expected to drive the market growth.
“The sinus lift segment in application segment is expected to grow with the highest CAGR in the dental bone graft substitute market.”
Dental bone graft substitutes play a crucial role in sinus lift procedures, a surgical technique used to increase jawbone height in the upper jaw before dental implant placement which is expected to drive the market growth. For instance, In autografts, the patient’s own bone is used, usually from the tibia, hip, chin, or jaw. Even while autografts have a great potential for osteogenesis, their use can result in donor site morbidity and limited bone supply.
“Based on the type, synthetic bone graft segment is expected to grow by the highest CAGR in the dental bone graft substitute market.
Synthetic bone grafts are typically composed of biocompatible materials like hydroxyapatite (similar to the mineral component of natural bone), calcium phosphates, or biopolymers. These materials provide a scaffold for bone ingrowth, promoting new bone formation at the graft site which is expected to drive the dental bone graft substitute market.
“Based on the product, bio OSS segment is expected to grow by the highest CAGR in the dental bone graft substitute market.
Bio-Oss provides a framework for bone cells to migrate, attach, and proliferate, promoting bone regeneration, Bio-Oss is used to augment the jawbone ridge before dental implant placement, providing a strong foundation for the implant which is expected to drive the dental bone graft substitute market. The main ingredient of Bio-Oss is processed bovine cancellous bone particles through a patented method that eliminates organic materials while maintaining the mineral structure. As a result, a biocompatible scaffold that closely mimics human bone is created, creating the perfect setting for the synthesis of new bone.
“Based on the end user, hospital segment is expected to grow by the highest CAGR in the dental bone graft substitute market.
Dental bone graft substitutes are increasingly valuable tools in hospital dentistry, offering a range of benefits for patients undergoing dental implant procedures, oral surgery, and treatments for jawbone defects. As technology advances and costs become more manageable, these materials are likely to play an even more prominent role in improving patient outcomes and expanding treatment options which is expected to drive the dental bone graft substitute market.
“North America to grow with the second highest CAGR in the dental bone graft substitute market during the forecast period.”
The growing elderly population in North America is more susceptible to tooth loss and jawbone deterioration, potentially requiring bone grafting procedures to support dental implants or other restorative treatments are fueling the expansion of the dental bone graft substitute market in North America.
Europe was the second largest segment in the dental bone graft substitute market in 2023. The Germany accounted for the larger share of the European dental bone graft substitute market in 2023. The rising number of dental disorders and and growing awareness regarding dental bone graft substitute is expected to drive the market growth in Europen market.
A breakdown of the primary participants (supply-side) for the dental bone graft substitute market referred to for this report is provided below:
• By Company Type: Tier 40%, Tier 35%, and Tier 25%
• By Designation: C-level–30%, Director Level–55%, and Others–15%
• By Region: North America–20%, Europe–15%, Asia Pacific–25%, Latin America- 10%, Middle East & Africa-30%.
Prominent players in the dental bone graft substitute market include Dentsply Sirona Inc. (US), Envista Holdings Corporation (US), JOHNSON & JOHNSON (US), Stryker Corporation (US), Medtronic, Plc (Ireland), Institut Straumann AG (Switzerland), Zimvie Inc. (US), Henry Schein Inc. (US), RTI Surgical Holdings Inc.(US), Lifenet Health (US), Dentium (US), Geistlich Pharma AG (Switzerland), Integra Lifesciences Holdings Corporation (US), Tissue Regenix Group (UK), Kuraray Co. Ltd. (Japan), BEGO GmbH & Co. KG (Germany), Young Innovations (US), Keystone Dental (US), Novabone LLC. (US), Biotiss Biomaterials LLC (US), Collagen Matrix Inc.(US), Osteogenics Biomedical (US), Hannox International Corp.(Taiwan), Meyer Haake GMBH (Germany) and Arora Biosurgery Ltd. (New Zealand).
Research Coverage:
The report analyzes the dental bone graft substitute market and aims at estimating the market size and future growth potential of this market based on various segments such as type, application, mechanism, product, end user and region. The report also includes a competitive analysis of the key players in this market along with their company profiles, product/service offerings, recent developments, and key market strategies.
Reasons to Buy the Report
The report will help the market leaders/new entrants in this market with information on the closest approximations of the revenue numbers for the overall dental bone graft substitute market and the subsegments. This report will help stakeholders understand the competitive landscape and gain more insights to position their businesses better and plan suitable go-to-market strategies. The report also helps stakeholders understand the pulse of the market and provides them with information on key market drivers, restraints, challenges, and opportunities.
This report provides insights into the following pointers:
Analysis of key drivers (growing market for dental tourism in emerging countries, increasing disposable income in developing counties, rising cases of dental caries and the subsequent increase in tooth repair procedures, changing demographics), restraints (lack of proper reimbursement scenario, stringent regulations pertaining to medical devices used in dentistry, dearth of trained dental practitioners), opportunities (increasing demand from customers and rising inclination towards cosmetic dentistry, low penetration rates for dental bone graft substitutes, consolidation of dental practices and rising dso activity, growing demand for bone graft substitutes from emerging markets) and challenges (pricing pressure faced by prominent market players)
• Market Penetration: It includes extensive information on product portfolios offered by the major players in the global dental bone graft substitute market. The report includes various segments in market type, application, mechanism, product, end user and region
• Product Enhancement/Innovation: Comprehensive details about new product launches and anticipated trends in the global dental bone graft substitute market.
• Market Development: Thorough knowledge and analysis of the profitable rising markets type, application, mechanism, product, end user and region
• Market Diversification: Comprehensive information about newly launched product and services, expanding markets, current advancements, and investments in the global dental bone graft substitute market.
• Competitive Assessment: Thorough evaluation of the market shares, growth plans, offerings of product and services, and capacities of the major competitors in the global dental bone graft substitute market.
Table of Contents
1 INTRODUCTION 35
1.1 STUDY OBJECTIVES 35
1.2 MARKET DEFINITION 35
1.3 STUDY SCOPE 36
1.3.1 MARKET SEGMENTATION 36
1.3.2 REGIONS COVERED 36
1.4 YEARS CONSIDERED 37
1.5 CURRENCY CONSIDERED 37
TABLE 1 STANDARD CURRENCY CONVERSION RATES, 2018–2022 37
1.6 KEY STAKEHOLDERS 38
1.7 SUMMARY OF CHANGES 38
1.7.1 RECESSION IMPACT 39
2 RESEARCH METHODOLOGY 40
2.1 RESEARCH DATA 40
FIGURE 1 RESEARCH DESIGN 40
2.1.1 SECONDARY DATA 41
2.1.1.1 Key data from secondary sources 42
2.1.2 PRIMARY DATA 43
FIGURE 2 KEY PRIMARY SOURCES 43
2.1.2.1 Key data from primary sources 44
2.1.2.2 Key industry insights 45
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND DEMAND-SIDE PARTICIPANTS 45
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS (SUPPLY SIDE): BY COMPANY TYPE, DESIGNATION, AND REGION 46
FIGURE 5 BREAKDOWN OF PRIMARY INTERVIEWS (DEMAND SIDE): BY END USER, DESIGNATION, AND REGION 46
2.2 MARKET SIZE ESTIMATION 47
FIGURE 6 SUPPLY-SIDE MARKET SIZE ESTIMATION: REVENUE SHARE ANALYSIS 47
FIGURE 7 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF TISSUE REGENIX GROUP PLC 48
FIGURE 8 DENTAL BONE GRAFT SUBSTITUTES MARKET: SUPPLY-SIDE MARKET SIZE ESTIMATION 49
FIGURE 9 CAGR PROJECTIONS FROM ANALYSIS OF DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 50
FIGURE 10 CAGR PROJECTIONS: SUPPLY-SIDE ANALYSIS 51
FIGURE 11 TOP-DOWN APPROACH 52
2.3 MARKET BREAKDOWN AND DATA TRIANGULATION 53
FIGURE 12 DATA TRIANGULATION METHODOLOGY 53
2.4 RESEARCH ASSUMPTIONS 54
2.5 LIMITATIONS 54
2.5.1 METHODOLOGY-RELATED LIMITATIONS 55
2.6 RISK ASSESSMENT 55
2.7 IMPACT OF RECESSION 55
3 EXECUTIVE SUMMARY 57
FIGURE 13 SYNTHETIC BONE GRAFT SEGMENT TO LEAD MARKET BY 2029 57
FIGURE 14 SOCKET PRESERVATION SEGMENT TO ACCOUNT FOR LARGEST SHARE IN 2024 58
FIGURE 15 OSTEOCONDUCTION SEGMENT TO LEAD MARKET BY 2029 58
FIGURE 16 BIO-OSS SEGMENT TO GROW AT HIGHEST CAGR DURING FORECAST PERIOD 59
FIGURE 17 HOSPITALS SEGMENT TO ACCOUNT FOR LARGEST SHARE BY 2029 59
FIGURE 18 DENTAL BONE GRAFT SUBSTITUTES MARKET: REGIONAL SNAPSHOT 60
4 PREMIUM INSIGHTS 61
4.1 OPPORTUNITIES FOR PLAYERS IN DENTAL BONE GRAFT SUBSTITUTES MARKET 61
FIGURE 19 RISING TECHNOLOGICAL ADVANCEMENTS TO DRIVE GROWTH OF DENTAL BONE GRAFT SUBSTITUTES MARKET 61
4.2 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER 62
FIGURE 20 HOSPITALS SEGMENT TO DOMINATE MARKET DURING FORECAST PERIOD 62
4.3 DENTAL BONE GRAFT SUBSTITUTES MARKET: GEOGRAPHIC SNAPSHOT 63
FIGURE 21 ASIA PACIFIC TO REGISTER HIGHEST CAGR DURING FORECAST PERIOD 63
4.4 DENTAL BONE GRAFT SUBSTITUTES MARKET: REGIONAL MIX 64
FIGURE 22 NORTH AMERICA TO BE LARGEST MARKET FOR DENTAL BONE GRAFT SUBSTITUTES DURING FORECAST PERIOD 64
4.5 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEVELOPED VS. DEVELOPING MARKETS 64
FIGURE 23 DEVELOPING MARKETS TO REGISTER HIGHER GROWTH DURING FORECAST PERIOD 64
5 MARKET OVERVIEW 65
5.1 INTRODUCTION 65
5.2 MARKET DYNAMICS 65
FIGURE 24 DENTAL BONE GRAFT SUBSTITUTES MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 65
5.2.1 DRIVERS 66
5.2.1.1 Growing market for dental tourism in emerging countries 66
5.2.1.2 Increasing disposable income in developing countries 66
5.2.1.3 Rising cases of dental caries and subsequent increase in tooth repair procedures 66
5.2.1.4 Changing demographics 67
5.2.2 RESTRAINTS 68
5.2.2.1 Lack of proper reimbursement scenario 68
5.2.2.2 Stringent regulations pertaining to medical devices used in dentistry 68
5.2.2.3 Dearth of trained dental practitioners 68
5.2.3 OPPORTUNITIES 68
5.2.3.1 Increasing demand from customers and rising inclination toward cosmetic dentistry 68
5.2.3.2 Low penetration rates for dental bone graft substitutes 69
5.2.3.3 Consolidation of dental practices and rising DSO activity 69
5.2.3.4 Growing demand for bone graft substitutes from emerging markets 70
5.2.4 CHALLENGES 70
5.2.4.1 Pricing pressure faced by prominent market players 70
6 INDUSTRY TRENDS 71
6.1 RISING NUMBER OF INDUSTRY-ACADEMIA COLLABORATIONS 71
6.2 HIGH INVESTMENT ACTIVITY IN DENTAL PRACTICES IN US AND UK 71
TABLE 2 EXAMPLES OF RECENT DEALS BACKED BY PRIVATE EQUITY IN US, 2020–2023 72
6.3 TECHNOLOGY ANALYSIS 73
6.3.1 GASLESS SPRAY TIP TECHNOLOGY 73
6.4 BIO CERAMICS 73
6.5 PRICING ANALYSIS 73
TABLE 3 AVERAGE SELLING PRICE TREND FOR KEY TYPES OF DENTAL BONE GRAFT SUBSTITUTES, BY REGION, 2021 (USD) 73
TABLE 4 AVERAGE SELLING PRICE TREND FOR KEY TYPES OF DENTAL BONE GRAFT SUBSTITUTES, BY REGION, 2022 (USD) 74
6.6 TARIFF AND REGULATORY LANDSCAPE 74
6.6.1 REGULATORY ANALYSIS 74
6.6.1.1 US 74
6.6.1.2 European Union 75
6.6.1.3 China 76
6.7 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 5 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 6 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 77
TABLE 7 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 78
6.8 VALUE CHAIN ANALYSIS 78
FIGURE 25 VALUE CHAIN ANALYSIS 79
6.9 PORTER’S FIVE FORCES ANALYSIS 80
TABLE 8 PORTER’S FIVE FORCES ANALYSIS 80
6.9.1 THREAT OF NEW ENTRANTS 80
6.9.2 THREAT OF SUBSTITUTES 81
6.9.3 BARGAINING POWER OF SUPPLIERS 81
6.9.4 BARGAINING POWER OF BUYERS 81
6.9.5 INTENSITY OF COMPETITIVE RIVALRY 81
6.10 SUPPLY CHAIN ANALYSIS 81
FIGURE 26 SUPPLY CHAIN ANALYSIS 82
6.11 TRADE ANALYSIS 82
TABLE 9 VALUE OF INSTRUMENTS AND APPLIANCES USED IN MEDICAL, SURGICAL, DENTAL, OR VETERINARY SCIENCES EXPORTED FROM US, 2019–2022 (000’) 83
6.12 PATENT ANALYSIS 83
6.13 PATENT PUBLICATION TRENDS FOR DENTAL BONE GRAFT SUBSTITUTES 83
FIGURE 27 PATENT PUBLICATION TRENDS (JANUARY 2013–SEPTEMBER 2023) 84
6.14 JURISDICTION ANALYSIS: TOP APPLICANTS FOR PATENTS IN DENTAL BONE GRAFT SUBSTITUTES MARKET 84
FIGURE 28 TOP PATENT APPLICANTS AND OWNERS (COMPANIES/INSTITUTES) FOR DENTAL BONE GRAFT SUBSTITUTES (JANUARY 2013–MARCH 2024) 85
FIGURE 29 TOP PATENT APPLICANT COUNTRIES FOR DENTAL BONE GRAFT SUBSTITUTES (JANUARY 2013–MARCH 2024) 85
6.15 CASE STUDIES 86
6.15.1 IDENTIFYING PREFERRED ANTIMICROBIAL AGENTS AND COATING SUBSTANCES USED FOR IMPLANT COATINGS 86
6.15.2 ANALYZING SHARE OF RADIOGRAPHY SYSTEMS IN DENTISTRY MARKET 87
6.16 KEY CONFERENCES & EVENTS 87
TABLE 10 DETAILED LIST OF CONFERENCES & EVENTS 87
6.17 KEY STAKEHOLDERS & BUYING CRITERIA 89
6.17.1 KEY STAKEHOLDERS IN BUYING PROCESS 89
FIGURE 30 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 89
TABLE 11 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR TOP THREE APPLICATIONS 89
6.17.2 BUYING CRITERIA 90
FIGURE 31 KEY BUYING CRITERIA FOR TOP THREE APPLICATIONS 90
6.18 ECOSYSTEM/MARKET MAP 90
FIGURE 32 ECOSYSTEM/MARKET MAP 91
6.18.1 ROLE OF PLAYERS IN MARKET ECOSYSTEM 91
6.19 ADJACENT MARKET ANALYSIS 92
FIGURE 33 DENTAL BONE GRAFT SUBSTITUTES MARKET: ADJACENT MARKETS 92
6.20 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 92
FIGURE 34 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 93
6.21 DENTAL BONE GRAFT SUBSTITUTES MARKET: UNMET NEEDS 93
6.22 ROLE OF ARTIFICIAL INTELLIGENCE (AI) IN DENTAL BONE GRAFT SUBSTITUTES MARKET 94
6.23 INVESTMENT/VENTURE CAPITAL 94
7 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION 95
7.1 INTRODUCTION 96
TABLE 12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 96
7.2 SOCKET PRESERVATION 96
7.2.1 SOCKET PRESERVATION REDUCES BONE LOSS AFTER TOOTH EXTRACTION 96
TABLE 13 SOCKET PRESERVATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 97
7.3 RIDGE AUGMENTATION 98
7.3.1 RIDGE AUGMENTATION RECREATES NATURAL CONTOUR OF GUMS AND JAW 98
TABLE 14 RIDGE AUGMENTATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 98
7.4 PERIODONTAL DEFECT REGENERATION 99
7.4.1 CHANGES IN LIFESTYLE AND EATING HABITS TO LEAD TO USE OF DENTAL BONE GRAFT SUBSTITUTES FOR PERIODONTAL DEFECT REGENERATION 99
TABLE 15 PERIODONTAL DEFECT REGENERATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 99
7.5 IMPLANT BONE REGENERATION 100
7.5.1 UTILIZATION OF GUIDED BONE REGENERATION MEMBRANES FACILITATES HEALING OF GRAFTED MATERIAL 100
TABLE 16 IMPLANT BONE REGENERATION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 100
7.6 SINUS LIFT 101
7.6.1 SINUS AUGMENTATION RAISES SINUS FLOOR AND DEVELOPS BONE FOR PLACEMENT OF DENTAL IMPLANTS 101
TABLE 17 SINUS LIFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 101
8 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER 102
8.1 INTRODUCTION 103
TABLE 18 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 103
8.2 HOSPITALS 103
8.2.1 INCREASING NUMBER OF COSMETIC DENTISTRY PROCEDURES ACROSS HOSPITALS TO DRIVE MARKET GROWTH 103
TABLE 19 HOSPITALS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 104
8.3 DENTAL CLINICS 105
8.3.1 HIGH-QUALITY SERVICES RENDERED BY DENTAL CLINICS’ STAFF TO DRIVE MARKET GROWTH 105
TABLE 20 NUMBER OF DENTAL CLINICS, BY COUNTRY, 2020 VS. 2022 105
TABLE 21 DENTAL CLINICS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 106
8.4 OTHER END USERS 106
TABLE 22 OTHER END USERS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 107
9 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM 108
9.1 INTRODUCTION 109
TABLE 23 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 109
9.2 OSTEOCONDUCTION 109
9.2.1 OSTEOCONDUCTION SERVES AS SCAFFOLD FOR BONE CELLS TO ATTACH, MIGRATE, GROW, AND DIVIDE 109
TABLE 24 OSTEOCONDUCTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 110
9.3 OSTEOINDUCTION 110
9.3.1 OSTEOINDUCTION FACILITATES BONE HEALING PROCESS 110
TABLE 25 OSTEOINDUCTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 111
9.4 OSTEOPROMOTION 112
9.4.1 OSTEOPROMOTION INVOLVES ENHANCEMENT OF OSTEOINDUCTION WITHOUT POSSESSION OF OSTEOINDUCTIVE PROPERTIES 112
TABLE 26 OSTEOPROMOTION: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 112
9.5 OSTEOGENESIS 113
9.5.1 OSTEOGENESIS PLAYS CRUCIAL ROLE IN FACILITATING SUCCESSFUL BONE REGENERATION AND REPAIR 113
TABLE 27 OSTEOGENESIS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 113
10 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT 114
10.1 INTRODUCTION 115
TABLE 28 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 115
10.2 BIO-OSS 115
10.2.1 HIGH IMPLANT SURVIVAL RATES ASSOCIATED WITH BIO-OSS PRODUCTS TO DRIVE MARKET GROWTH 115
TABLE 29 BIO-OSS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 116
10.3 OSTEOGRAF 117
10.3.1 NON-POROUS AND RESORBABLE NATURE OF OSTEOGRAF TO DRIVE MARKET GROWTH 117
TABLE 30 OSTEOGRAF: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 117
10.4 GRAFTON 118
10.4.1 INCREASED SAFETY AND LIMITED POSSIBILITY OF DISEASE TRANSMISSION TO BOOST DEMAND FOR GRAFTON 118
TABLE 31 GRAFTON: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 118
10.5 OTHER PRODUCTS 119
TABLE 32 OTHER PRODUCTS: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 119
11 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE 120
11.1 INTRODUCTION 121
TABLE 33 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 121
11.2 SYNTHETIC BONE GRAFT 122
11.2.1 INCREASING TECHNOLOGICAL ADVANCEMENTS TO INCREASE ADOPTION OF SYNTHETIC BONE GRAFT 122
TABLE 34 SYNTHETIC BONE GRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 123
11.3 XENOGRAFT 124
11.3.1 TECHNOLOGICAL ADVANCEMENTS IN USE OF XENOGRAFT MATERIALS AND SCARCITY OF ALLOGRAFT MATERIALS TO DRIVE MARKET 124
TABLE 35 XENOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 124
11.4 ALLOGRAFT 125
11.4.1 INCREASED OPERATING TIMELINES AND POTENTIAL COMPLICATIONS AND MORBIDITY OF HARVEST SITE TO BOOST USE OF ALLOGRAFT 125
TABLE 36 ALLOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 126
11.5 AUTOGRAFT 126
11.5.1 LITTLE SCOPE FOR DISEASE TRANSMISSION FROM GRAFT MATERIALS TO DRIVE ADOPTION OF AUTOGRAFT 126
TABLE 37 AUTOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 127
11.6 ALLOPLAST 128
11.6.1 ALLOPLAST MATERIALS PROMOTE BONE HEALING THROUGH OSTEOCONDUCTION 128
TABLE 38 ALLOPLAST: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 128
11.7 DEMINERALIZED ALLOGRAFT 129
11.7.1 DEMINERALIZED ALLOGRAFT POSSESSES MORE OSTEOINDUCTIVE PROPERTIES THAN REGULAR ALLOGRAFT 129
TABLE 39 DEMINERALIZED ALLOGRAFT: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 129
11.8 OTHER TYPES 130
TABLE 40 OTHER TYPES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 130
12 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY REGION 131
12.1 INTRODUCTION 132
FIGURE 35 US TO DOMINATE DENTAL BONE GRAFT SUBSTITUTES MARKET DURING FORECAST PERIOD 132
TABLE 41 DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 133
12.2 NORTH AMERICA 133
TABLE 42 US: DENTAL EXPENDITURE, 2011–2020 134
12.2.1 NORTH AMERICA: RECESSION IMPACT ANALYSIS 134
FIGURE 36 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT 135
TABLE 43 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 135
TABLE 44 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 136
TABLE 45 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 136
TABLE 46 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 137
TABLE 47 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 137
TABLE 48 NORTH AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 137
12.2.2 US 138
12.2.2.1 Increasing patient awareness about advantages of dental bone graft substitutes over traditional treatments to boost growth 138
TABLE 49 US: MACROECONOMIC INDICATORS 138
TABLE 50 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 139
TABLE 51 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 139
TABLE 52 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 140
TABLE 53 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 140
TABLE 54 US: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 140
12.2.3 CANADA 141
12.2.3.1 Rising geriatric population to propel market expansion 141
TABLE 55 CANADA: MACROECONOMIC INDICATORS 141
TABLE 56 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 142
TABLE 57 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 142
TABLE 58 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 143
TABLE 59 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 143
TABLE 60 CANADA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 143
12.3 EUROPE 144
12.3.1 EUROPE: RECESSION IMPACT ANALYSIS 144
FIGURE 37 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT 145
TABLE 61 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 146
TABLE 62 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 146
TABLE 63 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 147
TABLE 64 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 147
TABLE 65 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 147
TABLE 66 EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 148
12.3.2 GERMANY 148
12.3.2.1 Country’s robust health insurance system to drive popularity of dental bone graft substitutes 148
TABLE 67 GERMANY: MACROECONOMIC INDICATORS 148
TABLE 68 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 149
TABLE 69 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 149
TABLE 70 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 150
TABLE 71 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 150
TABLE 72 GERMANY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 150
12.3.3 UK 151
12.3.3.1 Preference for costly procedures due to availability of reimbursement facilities to lead to potential growth 151
TABLE 73 UK: MACROECONOMIC INDICATORS 151
TABLE 74 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 151
TABLE 75 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 152
TABLE 76 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 152
TABLE 77 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 152
TABLE 78 UK: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 153
12.3.4 FRANCE 153
12.3.4.1 Rising awareness among people regarding benefits of dental bone graft substitutes and presence of major players to drive growth 153
TABLE 79 FRANCE: MACROECONOMIC INDICATORS 154
TABLE 80 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 154
TABLE 81 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 155
TABLE 82 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 155
TABLE 83 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 155
TABLE 84 FRANCE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 156
12.3.5 ITALY 156
12.3.5.1 Intensive R&D and use of sophisticated materials to manufacture advanced products to propel market 156
TABLE 85 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 156
TABLE 86 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 157
TABLE 87 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 157
TABLE 88 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 157
TABLE 89 ITALY: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 158
12.3.6 SPAIN 158
12.3.6.1 Government initiatives to provide dental cover to people to boost market 158
TABLE 90 SPAIN: MACROECONOMIC INDICATORS 159
TABLE 91 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 159
TABLE 92 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 159
TABLE 93 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 160
TABLE 94 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 160
TABLE 95 SPAIN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 160
12.3.7 REST OF EUROPE 161
TABLE 96 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 161
TABLE 97 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 162
TABLE 98 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 162
TABLE 99 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 162
TABLE 100 REST OF EUROPE: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 163
12.4 ASIA PACIFIC 163
TABLE 101 DENTAL IMPLANTS PER 10,000 PEOPLE AND AVERAGE NUMBER OF IMPLANTS PLACED PER DENTIST, 2020 164
12.4.1 ASIA PACIFIC: RECESSION IMPACT ANALYSIS 164
FIGURE 38 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET SNAPSHOT 165
TABLE 102 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 166
TABLE 103 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 166
TABLE 104 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 167
TABLE 105 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 167
TABLE 106 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 167
TABLE 107 ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 168
12.4.2 JAPAN 168
12.4.2.1 Increasing awareness, availability of reimbursement, and growing income levels to offer growth opportunities for market players 168
TABLE 108 JAPAN: MACROECONOMIC INDICATORS 169
TABLE 109 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 110 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 170
TABLE 111 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 170
TABLE 112 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 170
TABLE 113 JAPAN: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION 171
12.4.3 CHINA 171
12.4.3.1 Growing geriatric population, economic boom, and increasing per capita income to propel growth 171
TABLE 114 CHINA: MACROECONOMIC INDICATORS 172
TABLE 115 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 172
TABLE 116 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 173
TABLE 117 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 173
TABLE 118 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 173
TABLE 119 CHINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION 174
12.4.4 INDIA 174
12.4.4.1 Diverse, lucrative opportunities offered to dental product and service providers to ensure adequate market progress 174
TABLE 120 INDIA: MACROECONOMIC INDICATORS 175
TABLE 121 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 175
TABLE 122 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 176
TABLE 123 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 176
TABLE 124 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 176
TABLE 125 INDIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION 177
12.4.5 AUSTRALIA 177
12.4.5.1 Popularity of xenograft and allograft to open new opportunities for growth of market players 177
TABLE 126 AUSTRALIA: ORAL HEALTH STATUS OF CHILDREN AND ADULTS 177
TABLE 127 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 178
TABLE 128 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 178
TABLE 129 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 179
TABLE 130 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 179
TABLE 131 AUSTRALIA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 179
12.4.6 SOUTH KOREA 180
12.4.6.1 Rising geriatric population and medical tourism to drive market 180
TABLE 132 NUMBER OF FOREIGN PATIENTS VISITING DENTAL FACILITIES IN SOUTH KOREA 180
TABLE 133 SOUTH KOREA: MACROECONOMIC INDICATORS 181
TABLE 134 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 181
TABLE 135 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 181
TABLE 136 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 182
TABLE 137 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 182
TABLE 138 SOUTH KOREA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION 182
12.4.7 REST OF ASIA PACIFIC 183
TABLE 139 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 183
TABLE 140 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 183
TABLE 141 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 184
TABLE 142 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 184
TABLE 143 REST OF ASIA PACIFIC: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION 184
12.5 LATIN AMERICA 185
12.5.1 LATIN AMERICA: RECESSION IMPACT ANALYSIS 185
TABLE 144 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY COUNTRY/REGION, 2022–2029 (USD MILLION) 186
TABLE 145 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 186
TABLE 146 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 187
TABLE 147 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 187
TABLE 148 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 187
TABLE 149 LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 188
12.5.2 BRAZIL 188
12.5.2.1 Improving healthcare infrastructure and rising investments by leading players to spur demand 188
TABLE 150 BRAZIL: MACROECONOMIC INDICATORS 188
TABLE 151 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 189
TABLE 152 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 189
TABLE 153 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 190
TABLE 154 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 190
TABLE 155 BRAZIL: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 190
12.5.3 MEXICO 191
12.5.3.1 Rising medical tourism to support market growth 191
TABLE 156 MEXICO: MACROECONOMIC INDICATORS 191
TABLE 157 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 192
TABLE 158 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 192
TABLE 159 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 193
TABLE 160 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 193
TABLE 161 MEXICO: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 193
12.5.4 ARGENTINA 194
12.5.4.1 Growing demand for personalized dentistry to spur market demand 194
TABLE 162 ARGENTINA: MACROECONOMIC INDICATORS 194
TABLE 163 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 194
TABLE 164 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 195
TABLE 165 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 195
TABLE 166 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 195
TABLE 167 ARGENTINA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 196
12.5.5 REST OF LATIN AMERICA 196
TABLE 168 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 169 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 197
TABLE 170 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 197
TABLE 171 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 197
TABLE 172 REST OF LATIN AMERICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 198
12.6 MIDDLE EAST & AFRICA 198
12.6.1 GROWING INVESTMENTS IN DIGITAL HEALTHCARE INDUSTRY TO BOOST DEMAND FOR DENTAL BONE GRAFT SUBSTITUTES 198
12.6.2 MIDDLE EAST & AFRICA: RECESSION IMPACT ANALYSIS 198
TABLE 173 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 199
TABLE 174 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 199
TABLE 175 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 200
TABLE 176 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 200
TABLE 177 MIDDLE EAST & AFRICA: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 200
12.7 GCC COUNTRIES 201
12.7.1 INCREASING DEMAND FOR HEALTH SERVICES DUE TO POPULATION GROWTH TO DRIVE MARKET FOR DENTAL BONE GRAFT SUBSTITUTES 201
12.7.2 GCC COUNTRIES: RECESSION IMPACT ANALYSIS 201
TABLE 178 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2029 (USD MILLION) 201
TABLE 179 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 202
TABLE 180 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 202
TABLE 181 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY MECHANISM, 2022–2029 (USD MILLION) 202
TABLE 182 GCC COUNTRIES: DENTAL BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2029 (USD MILLION) 203
13 COMPETITIVE LANDSCAPE 204
13.1 INTRODUCTION 204
13.2 KEY MARKET DEVELOPMENTS 204
13.3 KEY PLAYERS’ STRATEGIES 205
13.4 REVENUE ANALYSIS OF KEY MARKET PLAYERS 205
FIGURE 39 REVENUE SHARE ANALYSIS OF KEY PLAYERS OPERATING IN DENTAL BONE GRAFT SUBSTITUTES MARKET 206
13.5 MARKET SHARE ANALYSIS 206
FIGURE 40 MARKET SHARE ANALYSIS, BY KEY PLAYER, 2023 207
TABLE 183 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEGREE OF COMPETITION 207
13.6 COMPETITIVE SITUATION AND TRENDS 208
13.6.1 PRODUCT LAUNCHES & APPROVALS 208
TABLE 184 DENTAL BONE GRAFT SUBSTITUTES MARKET: PRODUCT LAUNCHES & APPROVALS, MAY 2020–DECEMBER 2021 209
13.6.2 DEALS 209
TABLE 185 DENTAL BONE GRAFT SUBSTITUTES MARKET: DEALS, DECEMBER 2022–JANUARY 2024 209
13.6.3 EXPANSIONS 210
TABLE 186 DENTAL BONE GRAFT SUBSTITUTES MARKET: EXPANSIONS, APRIL 2021 210
13.7 COMPANY EVALUATION MATRIX: KEY PLAYERS 211
13.7.1 STARS 211
13.7.2 EMERGING LEADERS 211
13.7.3 PERVASIVE PLAYERS 211
13.7.4 EMERGING PLAYERS 211
FIGURE 41 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX (KEY PLAYERS), 2023 212
13.7.5 FOOTPRINT ANALYSIS 213
FIGURE 42 OVERALL COMPANY FOOTPRINT 213
TABLE 187 COMPANY PRODUCT FOOTPRINT 214
TABLE 188 COMPANY APPLICATION FOOTPRINT 215
TABLE 189 COMPANY MECHANISM FOOTPRINT 216
TABLE 190 COMPANY END USER FOOTPRINT 217
TABLE 191 COMPANY REGIONAL FOOTPRINT 218
13.8 COMPANY EVALUATION MATRIX: START-UPS/SMES 219
13.8.1 PROGRESSIVE COMPANIES 219
13.8.2 STARTING BLOCKS 219
13.8.3 RESPONSIVE COMPANIES 219
13.8.4 DYNAMIC COMPANIES 219
FIGURE 43 DENTAL BONE GRAFT SUBSTITUTES MARKET: COMPANY EVALUATION MATRIX (START-UPS/SMES), 2023 220
13.8.5 COMPETITIVE BENCHMARKING 221
TABLE 192 DENTAL BONE GRAFT SUBSTITUTES MARKET: DETAILED LIST OF KEY START-UPS/SMES 221
13.9 BRAND/PRODUCT COMPARATIVE ANALYSIS 222
13.10 R&D EXPENDITURE OF KEY PLAYERS 223
13.11 INVESTMENT LANDSCAPE 223
FIGURE 44 DENTAL BONE GRAFT SUBSTITUTES MARKET: FUNDING ANALYSIS, 2019–2023 223
FIGURE 45 MOST VALUED FIRMS IN DENTAL BONE GRAFT SUBSTITUTES MARKET, 2023 (USD BILLION) 224
13.12 VALUATION AND FINANCIAL MATRICES OF DENTAL BONE GRAFT SUBSTITUTES MARKET 224
14 COMPANY PROFILES 225
14.1 KEY PLAYERS 225
(Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
14.1.1 DENTSPLY SIRONA INC. 225
TABLE 193 DENTSPLY SIRONA INC.: BUSINESS OVERVIEW 225
FIGURE 46 DENTSPLY SIRONA INC.: COMPANY SNAPSHOT 226
TABLE 194 DENTSPLY SIRONA INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 226
TABLE 195 DENTSPLY SIRONA INC.: DEALS 227
14.1.2 ENVISTA HOLDINGS CORPORATION 229
TABLE 196 ENVISTA HOLDINGS CORPORATION: BUSINESS OVERVIEW 229
FIGURE 47 ENVISTA HOLDINGS CORPORATION: COMPANY SNAPSHOT 230
TABLE 197 ENVISTA HOLDINGS CORPORATION: PRODUCTS/SERVICES/
SOLUTIONS OFFERED 230
TABLE 198 ENVISTA HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS 231
TABLE 199 ENVISTA HOLDINGS CORPORATION: DEALS 231
14.1.3 JOHNSON & JOHNSON 233
TABLE 200 JOHNSON & JOHNSON: BUSINESS OVERVIEW 233
FIGURE 48 JOHNSON & JOHNSON: COMPANY SNAPSHOT 234
TABLE 201 JOHNSON & JOHNSON: PRODUCTS/SERVICES/SOLUTIONS OFFERED 234
TABLE 202 JOHNSON & JOHNSON: DEALS 235
14.1.4 INSTITUT STRAUMANN AG 236
TABLE 203 INSTITUT STRAUMANN AG: BUSINESS OVERVIEW 236
FIGURE 49 INSTITUT STRAUMANN AG: COMPANY SNAPSHOT 237
TABLE 204 INSTITUT STRAUMANN AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 238
TABLE 205 INSTITUT STRAUMANN AG: PRODUCT LAUNCHES & APPROVALS 238
TABLE 206 INSTITUT STRAUMANN AG : DEALS 239
TABLE 207 INSTITUT STRAUMANN AG: OTHER DEVELOPMENTS 239
14.1.5 MEDTRONIC, PLC 241
TABLE 208 MEDTRONIC, PLC: BUSINESS OVERVIEW 241
FIGURE 50 MEDTRONIC, PLC: COMPANY SNAPSHOT 242
TABLE 209 MEDTRONIC, PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 242
TABLE 210 MEDTRONIC PLC: DEALS 243
TABLE 211 MEDTRONIC PLC: EXPANSIONS 243
14.1.6 ZIMVIE INC. 244
TABLE 212 ZIMVIE INC.: BUSINESS OVERVIEW 244
FIGURE 51 ZIMVIE INC.: COMPANY SNAPSHOT 244
TABLE 213 ZIMVIE INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 245
TABLE 214 ZIMVIE INC: DEALS 245
14.1.7 HENRY SCHEIN, INC. 246
TABLE 215 HENRY SCHEIN, INC.: BUSINESS OVERVIEW 246
FIGURE 52 HENRY SCHEIN, INC.: COMPANY SNAPSHOT 247
TABLE 216 HENRY SCHEIN, INC.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 247
TABLE 217 HENRY SCHEIN, INC.: PRODUCT LAUNCHES & APPROVALS 248
TABLE 218 HENRY SCHEIN, INC.: DEALS 248
14.1.8 RTI SURGICAL 250
TABLE 219 RTI SURGICAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 250
TABLE 220 RTI SURGICAL: DEALS 250
14.1.9 LIFENET HEALTH 251
TABLE 221 LIFENET HEALTH: PRODUCTS/SERVICES/SOLUTIONS OFFERED 251
14.1.10 DENTIUM CO., LTD. 252
TABLE 222 DENTIUM CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 252
14.1.11 GEISTLICH PHARMA AG 253
TABLE 223 GEISTLICH PHARMA AG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 253
14.1.12 STRYKER CORPORATION 254
TABLE 224 STRYKER CORPORATION: BUSINESS OVERVIEW 254
FIGURE 53 STRYKER CORPORATION: COMPANY SNAPSHOT 255
TABLE 225 STRYKER CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 255
TABLE 226 STRYKER CORPORATION: DEALS 257
14.1.13 INTEGRA LIFESCIENCES HOLDINGS CORPORATION 258
TABLE 227 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: BUSINESS OVERVIEW 258
FIGURE 54 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: COMPANY SNAPSHOT 259
TABLE 228 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCTS/SERVICES/SOLUTIONS OFFERED 259
TABLE 229 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: PRODUCT LAUNCHES & APPROVALS 261
TABLE 230 INTEGRA LIFESCIENCES HOLDINGS CORPORATION: DEALS 261
14.1.14 TISSUE REGENIX GROUP PLC 262
TABLE 231 TISSUE REGENIX GROUP PLC: BUSINESS OVERVIEW 262
FIGURE 55 TISSUE REGENIX GROUP PLC: COMPANY SNAPSHOT 262
TABLE 232 TISSUE REGENIX GROUP PLC: PRODUCTS/SERVICES/SOLUTIONS OFFERED 263
TABLE 233 TISSUE REGENIX GROUP PLC: PRODUCT LAUNCHES & APPROVALS 263
TABLE 234 TISSUE REGENIX GROUP PLC: DEALS 263
TABLE 235 TISSUE REGENIX GROUP PLC: OTHER DEVELOPMENTS 264
14.1.15 KURARAY CO., LTD. 265
TABLE 236 KURARAY CO., LTD.: BUSINESS OVERVIEW 265
FIGURE 56 KURARAY CO., LTD.: COMPANY SNAPSHOT 265
TABLE 237 KURARAY CO., LTD.: PRODUCTS/SERVICES/SOLUTIONS OFFERED 266
TABLE 238 KURARAY CO., LTD.: DEALS 266
TABLE 239 KURARAY CO., LTD.: OTHER DEVELOPMENTS 266
14.1.16 BEGO GMBH & CO. KG 267
TABLE 240 BEGO GMBH & CO. KG: BUSINESS OVERVIEW 267
TABLE 241 BEGO GMBH & CO. KG: PRODUCTS/SERVICES/SOLUTIONS OFFERED 267
TABLE 242 BEGO GMBH & CO. KG: DEALS 268
14.1.17 YOUNG INNOVATIONS 269
TABLE 243 YOUNG INNOVATIONS: BUSINESS OVERVIEW 269
TABLE 244 YOUNG INNOVATIONS: PRODUCTS/SERVICES/SOLUTIONS OFFERED 269
TABLE 245 YOUNG INNOVATIONS: DEALS 269
14.1.18 KEYSTONE DENTAL 270
TABLE 246 KEYSTONE DENTAL: BUSINESS OVERVIEW 270
TABLE 247 KEYSTONE DENTAL: PRODUCTS/SERVICES/SOLUTIONS OFFERED 270
TABLE 248 KEYSTONE DENTAL: DEALS 271
14.2 OTHER PLAYERS 271
14.2.1 NOVABONE 271
14.2.2 BOTISS BIOMATERIALS GMBH 272
14.2.3 REGENITY 273
14.2.4 OSTEOGENICS BIOMEDICAL 273
14.2.5 HANNOX INTERNATIONAL CORP. 274
14.2.6 MEYER-HAAKE GMBH 274
14.2.7 AROA BIOSURGERY LTD. 275
*Details on Business Overview, Products Offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
15 APPENDIX 276
15.1 DISCUSSION GUIDE 276
15.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 280
15.3 CUSTOMIZATION OPTIONS 282
15.4 RELATED REPORTS 282
15.5 AUTHOR DETAILS 283